source
- NEJM retracts pivotal data for Amgen's Tavneos, adding new hurdle for the autoimmune drugThe New England Journal of Medicine has withdrawn the pivotal data that supported Amgen’s autoimmune therapy Tavneos. The retraction was requested by two academic authors who raised concerns about…
- FDA picks seven firms for PreCheck pilot to boost U.S. drug manufacturingThe FDA announced on June 29, 2026 that seven companies have been chosen for its PreCheck Pilot Program, an initiative aimed at strengthening U.S. drug manufacturing and supply chain resilience. T…